News & Resources

Clinical Trials on Alzheimer’s Disease (CTAD) Poster 2019

A fully automatic pipeline for estimation of regional brain volume change using Jacobian integration

Clinical Trials on Alzheimer’s Disease (CTAD) Poster 2019

A pipeline for automated diffusion MRI analysis: overview and application to the study of Alzheimer’s Disease

Company Annual Report 2019

Huntington Study Group (HSG) Annual Meeting Poster 2019

A Fully Automatic Pipeline for Estimation of Putamen and Caudate Volume

• Date: 15/10/2019

Investors chronicle: 'IXICO upgrades guidance again'

Published on investors chronicle: 15th October Author: Simon Thompson The world’s largest biopharmaceutical companies are investing huge sums of money in the field of neurology to target therapies for diseases affecting the central nervous system including Huntington’s, Alzheimer’s and Parkinson’s disease.

Spinocerebellar Ataxias (SCA) Global Conference 2019 Poster

Development of a fully automated method for MRI volumetry in ataxia

Clinical Trials on Alzheimer’s Disease (CTAD) 2017 Poster

Extracting digital biomarkers of sleep from 3-axis accelerometry using Deep Learning

• Date: 22/07/2019

Investors chronicle: 'Profit from artificial intelligence in neuroscience'

Published on investors chronicle: 22nd July, 2019 Author: Simon Thompson IXICO may be a small-cap London-based company well under the radar of investors, but it is highly regarded by pharmaceutical and biotechnology companies and huge corporations are increasingly awarding the company new contracts.